For decades now, researchers have been trying, without success, to develop drugs that slow or prevent Alzheimer’s. Now research at suggests that while the protein they have been focusing on-- amyloid-beta -- is the right one, what’s needed is to direct a drug to a very specific location, which they’ve discovered, on that protein.